Javier de Miguel-Díez1, Rodrigo Jiménez-García2, Valentín Hernández-Barrera2, Isabel Jiménez-Trujillo2, José M de Miguel-Yanes3, Manuel Méndez-Bailón4, Ana López-de-Andrés2. 1. Respiratory Department, Hospital General Universitario Gregorio Marañón, Facultad de Medicina, Universidad Complutense de Madrid (UCM), Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain. Electronic address: javier.miguel@salud.madrid.org. 2. Preventive Medicine and Public Health Teaching and Research Unit, Health Sciences Faculty, Rey Juan Carlos University, Alcorcón, Madrid, Spain. 3. Internal Medicine Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain. 4. Internal Medicine Department, Hospital Universitario Clínico San Carlos, Madrid, Spain.
Abstract
AIM: To describe trends in the incidence and outcomes of community-acquired pneumonia (CAP) hospitalizations in Spain (2004-2013). METHODS: We used national hospital discharge data to select all hospital admissions for CAP as primary diagnosis. We analyzed incidence, Charlson comorbidity index (CCI), diagnostic and therapeutic procedures, pathogens, length of hospital stay (LOHS), in-hospital mortality (IHM) and readmission. RESULTS: We identified 959,465 admissions for CAP. Incidence rates of CAP increased significantly over time (from 142.4 in 2004 to 163.87 cases per 100,000 inhabitants in 2013). Time trend analyses showed significant increases in the number of comorbidities and the use of CAT of thorax, red cell transfusion, non-invasive mechanical ventilation and readmissions (all p values<0.05). S. pneumoniae was the most frequent causative agent, but its isolation decreased over time. Overall median of LOHS was 7days and it did not change significantly during the study period. Time trend analyses also showed significant decreases in mortality during admission for CAP. Factor associated with higher IHM included: older age, higher CCI, S. aureus isolated, use of red cell transfusion or mechanical ventilation and readmission. CONCLUSIONS: The incidence and mortality of CAP have changed in Spain from 2004 to 2013. Although there was an increased incidence of hospitalization for this disease over time, we saw a significant reduction in IHM.
AIM: To describe trends in the incidence and outcomes of community-acquired pneumonia (CAP) hospitalizations in Spain (2004-2013). METHODS: We used national hospital discharge data to select all hospital admissions for CAP as primary diagnosis. We analyzed incidence, Charlson comorbidity index (CCI), diagnostic and therapeutic procedures, pathogens, length of hospital stay (LOHS), in-hospital mortality (IHM) and readmission. RESULTS: We identified 959,465 admissions for CAP. Incidence rates of CAP increased significantly over time (from 142.4 in 2004 to 163.87 cases per 100,000 inhabitants in 2013). Time trend analyses showed significant increases in the number of comorbidities and the use of CAT of thorax, red cell transfusion, non-invasive mechanical ventilation and readmissions (all p values<0.05). S. pneumoniae was the most frequent causative agent, but its isolation decreased over time. Overall median of LOHS was 7days and it did not change significantly during the study period. Time trend analyses also showed significant decreases in mortality during admission for CAP. Factor associated with higher IHM included: older age, higher CCI, S. aureus isolated, use of red cell transfusion or mechanical ventilation and readmission. CONCLUSIONS: The incidence and mortality of CAP have changed in Spain from 2004 to 2013. Although there was an increased incidence of hospitalization for this disease over time, we saw a significant reduction in IHM.
Authors: M A Fernandez-Sierra; M T Rueda-Domingo; M M Rodriguez-Del-Aguila; M J Perez-Lozano; L Force; T Fernandez-Villa; J Astray; M Egurrola; J Castilla; F Sanz; D Toledo; A Dominguez Journal: Epidemiol Infect Date: 2018-08-02 Impact factor: 4.434
Authors: Ana Lopez-de-Andres; Romana Albaladejo-Vicente; Javier de Miguel-Diez; Valentin Hernandez-Barrera; Zichen Ji; Jose J Zamorano-Leon; Marta Lopez-Herranz; Rodrigo Jimenez-Garcia Journal: BMJ Open Diabetes Res Care Date: 2020-06
Authors: José María Galván-Román; Ángel Lancho-Sánchez; Sergio Luquero-Bueno; Lorena Vega-Piris; Jose Curbelo; Marcos Manzaneque-Pradales; Manuel Gómez; Hortensia de la Fuente; Mara Ortega-Gómez; Javier Aspa Journal: PLoS One Date: 2020-10-23 Impact factor: 3.240
Authors: Zichen Ji; Julio Hernández Vázquez; José María Bellón Cano; Virginia Gallo González; Beatriz Recio Moreno; Alicia Cerezo Lajas; Luis Puente Maestu; Javier de Miguel Díez Journal: J Clin Med Date: 2020-01-15 Impact factor: 4.241